European Commission Grants Marketing Authorization for GSK’s Nucala (mepolizumab) For Adult Asthma
Asthma, News
GlaxoSmithKline (GSK) announced in a press release that Nucala® (mepolizumab) has been granted marketing authorization as an add-on treatment by the European Commission. After receiving Food and Drug Administration (FDA) approval ... Read more